Skip to main content
SpringerLink
Log in

Ozone-friendly asthma inhalers race to market

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

In response to the growing evidence of the detrimental effect that chlorofluorocarbons (CFCs) are having on the environment, 3M Pharmaceuticals and Glaxo have developed CFC-free systems for metered-dose inhalers used to treat asthma. Both systems use hydrofluoroalkane 134a (HFA-134a) as a propellant, and are currently in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Robert Short
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Short, R. Ozone-friendly asthma inhalers race to market. Inpharma Wkly. 943, 3 (1994). https://doi.org/10.2165/00128413-199409430-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199409430-00002

Keywords

Search

Navigation